Zynerba Pharmaceuticals Inc (ZYNE)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

80 W. LANCASTER AVENUE DEVON, PA 19333

Zynerba Pharmaceuticals is the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. Zynerba Pharmaceuticals is committed to improving the lives of patients and their families living with severe, chronic health conditions including Fragile X syndrome, auti® spectrum disorder, 22q11.2 deletion syndrome, and a heterogeneous group of rare and ultra-rare epilepsies known as developmental and epileptic encephalopathies.

Data as of 2021-10-09 10:20:26 -0400
Market Cap167.069 Million Shares Outstanding41.252 Million Avg 30-day Volume1.239 Million
P/E Ratio0.0 Dividend Yield0.0 EPS0
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-3.94 Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.43668 52-week High/Low9.0 / 3.15 Next Earnings Date2021-11-08 Price to Cash FLow (P/CF) -22.3869
Data provided by IEX Cloud
View SEC Filings from ZYNE instead.

View recent insider trading info

Funds Holding ZYNE (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ZYNE BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MOCH KENNETH I

  • Director
12,500 2021-08-03 1

KISNER DANIEL L

  • Director
12,500 2021-08-03 1

COOPER WARREN D

  • Director
12,500 2021-08-03 1

FEDERICI WILLIAM J

  • Director
12,500 2021-08-03 1

BUTLER JOHN P.

  • Director
17,500 2021-08-03 1

STEPHENSON PAMELA

  • Director
12,500 2021-08-03 1

ANIDO ARMANDO CHAIRMAN & CHIEF EXEC. OFFICER

  • Officer
  • Director
500,315 2021-01-21 1

SEBREE TERRI B PRESIDENT

  • Officer
261,146 2021-01-21 1

FICKENSCHER JAMES E CHIEF FINANCIAL OFFICER

  • Officer
72,718 2021-01-21 1

HANLON SUZANNE M. SEC, VP & GENERAL COUNSEL

  • Officer
80,693 2021-01-21 1

ROSENBERGER BRIAN VP, COMMERCIAL & BUSINESS DEV.

  • Officer
37,000 2021-01-21 1

HARRISON THOMAS L

  • Director
0 2018-06-06 0

RAPP MICHAEL

  • 10% Owner
1,500,000 2018-05-30 0

RASK CYNTHIA ANN

  • Director
0 2017-07-03 0

BARON RICHARD A CHIEF FINANCIAL OFFICER

  • Officer
15,957 2015-09-11 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
ZYNERBA PHARMACEUTICALS INC ZYNE 2021-10-15 22:15:04 UTC -1.8334 1.9034 850000
ZYNERBA PHARMACEUTICALS INC ZYNE 2021-10-15 21:45:03 UTC -1.8281 1.8981 850000
ZYNERBA PHARMACEUTICALS INC ZYNE 2021-10-15 21:15:03 UTC -1.8281 1.8981 850000
ZYNERBA PHARMACEUTICALS INC ZYNE 2021-10-15 20:45:03 UTC -1.762 1.832 800000
ZYNERBA PHARMACEUTICALS INC ZYNE 2021-10-15 20:15:03 UTC -1.762 1.832 800000
ZYNERBA PHARMACEUTICALS INC ZYNE 2021-10-15 19:45:03 UTC -1.762 1.832 800000
ZYNERBA PHARMACEUTICALS INC ZYNE 2021-10-15 19:15:04 UTC -1.762 1.832 800000
ZYNERBA PHARMACEUTICALS INC ZYNE 2021-10-15 18:45:03 UTC -1.5751 1.6451 800000
ZYNERBA PHARMACEUTICALS INC ZYNE 2021-10-15 18:15:03 UTC -1.5751 1.6451 800000
ZYNERBA PHARMACEUTICALS INC ZYNE 2021-10-15 17:45:03 UTC -1.5751 1.6451 800000
ZYNERBA PHARMACEUTICALS INC ZYNE 2021-10-15 17:15:03 UTC -1.5751 1.6451 800000
ZYNERBA PHARMACEUTICALS INC ZYNE 2021-10-15 16:45:03 UTC -1.5271 1.5971 800000
ZYNERBA PHARMACEUTICALS INC ZYNE 2021-10-15 16:15:03 UTC -1.5271 1.5971 800000
ZYNERBA PHARMACEUTICALS INC ZYNE 2021-10-15 15:45:03 UTC -1.5271 1.5971 800000
ZYNERBA PHARMACEUTICALS INC ZYNE 2021-10-15 15:15:03 UTC -1.5271 1.5971 850000
ZYNERBA PHARMACEUTICALS INC ZYNE 2021-10-15 14:45:02 UTC -1.7303 1.8003 850000
ZYNERBA PHARMACEUTICALS INC ZYNE 2021-10-15 14:15:03 UTC -1.7303 1.8003 850000
ZYNERBA PHARMACEUTICALS INC ZYNE 2021-10-15 13:45:03 UTC -1.7303 1.8003 850000
ZYNERBA PHARMACEUTICALS INC ZYNE 2021-10-15 13:15:03 UTC -1.7303 1.8003 850000
ZYNERBA PHARMACEUTICALS INC ZYNE 2021-10-15 12:45:03 UTC -1.7303 1.8003 850000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments